Gemini 說了
Founded in 1980 and headquartered in Thousand Oaks, California, Amgen is a global biotechnology pioneer that transformed the industry with breakthrough therapies like Epogen and Neupogen. Today, it is a diversified biopharmaceutical giant specializing in oncology, inflammation, bone health, and rare diseases. With 2025 revenue reaching $36.8B, Amgen is currently leveraging its robust biosimilar portfolio and advancing high-growth candidates like MariTide for obesity to maintain its leadership in the competitive pharmaceutical landscape.
Here are some articles to give you a basic understanding of the company:
Amgen – background and history
Below is a list of articles for the company:
-
Amgen – FY25 results
Amgen (AMGN) reported its fourth-quarter and full-year 2025 financial results on February 3, 2026. Below is the summary of the income statement, balance sheet, and pipeline highlights based on the report. Income Statement Summary Unit: USD millions (except per share data) Item 2025 Q4 YoY % 2025 FY YoY % Total Revenues 9,900 +9% 36,751…
-
Amgen – History and Competitions
Amgen’s history is a definitive narrative of the biotechnology industry’s evolution, transitioning from a venture-backed startup in Thousand Oaks to a global biopharmaceutical titan. Here is the breakdown of Amgen’s history by phase: 1. The Founding and Scientific Exploration (1980–1983) Amgen was founded on April 8, 1980, as Applied Molecular Genetics (AMGen). 2. The Era…